Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV-AIDS
Podcast
What 'The Next Berlin Patient' means for HIV drug development
This week on “The Top Line,” we dive into two studies in HIV research that were presented at the 25th International AIDS Conference in Germany.
Ayla Ellison
,
Angus Liu
Aug 2, 2024 9:43am
GSK's Dovato matches Gilead's Biktarvy with less weight gain
Jul 23, 2024 4:00am
Gilead funding aimed at Black women and girls impacted by HIV
Feb 28, 2024 9:50am
Pfizer, Gilead, GSK to dominate infectious disease market
Jul 20, 2023 9:45am
ViiV brings together sons and mothers in new initiative for HIV
May 30, 2023 7:15am
GSK's Cabenuva matches Gilead's Biktarvy in head-to-head study
Feb 22, 2023 11:00am
